RKIP inhibits local breast cancer invasion by antagonizing the transcriptional activation of MMP13

Ila Datar, Jingwei Feng, Xiaoliang Qiu, John Lewandowski, Miranda Yeung, Gang Ren, Shweta Aras, Fahd Al-Mulla, Hongjuan Cui, Robert Trumbly, Sri Krishna Chaitanya Arudra, Luis E. De Las Casas, Ivana De La Serna, Milad Sami Bitar, Kam C. Yeung

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Raf Kinase Inhibitory Protein or RKIP was initially identified as a Raf-1 binding protein using the yeast 2-hybrid screen. RKIP inhibits the activation phosphorylation ofMEK by Raf-1 by competitively inhibiting the binding of MEK to Raf-1 and thus exerting an inhibitory effect on the Raf-MEK-Erk pathway. RKIP has been identified as a metastasis suppressor gene. Expression of RKIP is low in cancermetastases. Although primary tumor growth remains unaffected, re- expression of RKIP inhibits cancer metastasis. Mechanistically, RKIP constrainsmetastasis by inhibiting angiogenesis, local invasion, intravasation, and colonization. Themolecular mechanism of how RKIP inhibits these individual steps remains undefined. In our present study, using an unbiased PCR based screening and by analyzing DNA microarray expression datasets we observe that the expression of multiple metaloproteases (MMPs) including MMP1, MMP3, MMP10 and MMP13 are negatively correlated with RKIP expression in breast cancer cell lines and clinical samples. Since expression of MMPs by cancer cells is important for cancer metastasis, we hypothesize that RKIP may mediate suppression of breast cancer metastasis by inhibiting multiple MMPs. We show that the expression signature of RKIP and MMPs is better at predicting highmetastatic risk than the individual gene. Using a combination of loss- and gain-of-function approaches, we find that MMP13 is the cause of RKIP-mediated inhibition of local cancer invasion. Interestingly expression ofMMP13 alone is not sufficient to reverse the inhibition of breast cancer cellmetastasis to the lung due to the expression of RKIP. We find that RKIP negatively regulatesMMP13 through the Erk2 signaling pathway and the repression of MMP13 by RKIP is transcription factor AP-1 independent. Together, our findings indicate that RKIP inhibits cancer cell invasion, in part, via MMP13 inhibition. These data also implicate RKIP in the regulation of MMP transcription, suggesting a potential mechanism by which RKIP inhibits tumor progression and metastasis.

Original languageEnglish
Article numbere0134494
JournalPloS one
Volume10
Issue number8
DOIs
Publication statusPublished - 26 Aug 2015

Fingerprint Dive into the research topics of 'RKIP inhibits local breast cancer invasion by antagonizing the transcriptional activation of MMP13'. Together they form a unique fingerprint.

  • Cite this

    Datar, I., Feng, J., Qiu, X., Lewandowski, J., Yeung, M., Ren, G., Aras, S., Al-Mulla, F., Cui, H., Trumbly, R., Arudra, S. K. C., De Las Casas, L. E., De La Serna, I., Sami Bitar, M., & Yeung, K. C. (2015). RKIP inhibits local breast cancer invasion by antagonizing the transcriptional activation of MMP13. PloS one, 10(8), [e0134494]. https://doi.org/10.1371/journal.pone.0134494